Eupraxia Pharmaceuticals Inc. (TSX: EPRX)
Canada
· Delayed Price · Currency is CAD 4.640
+0.010 (0.22%)
Jan 20, 2025, 3:59 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 164.93 million as of January 17, 2025. Its market cap has increased by 5.50% in one year.
Market Cap
164.93M
Enterprise Value
151.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.64
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 164.93M, an increase of 111.43%. That is a compound annual growth rate of 21.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 164.93M | 2.66% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.54B |
| Curaleaf Holdings | 1.64B |
| WELL Health Technologies | 1.63B |
| dentalcorp Holdings | 1.56B |
| Trulieve Cannabis | 1.37B |
| Sienna Senior Living | 1.25B |
| Cronos Group | 1.10B |
| Extendicare | 863.05M |